Call: +44 (0) 20 7079 4344
Professor Kefah Mokbel outlines optimum treatment for DCIS
LBI Research Team have Reported a Tumour Suppressor Role for Dok2 and Dok6 Genes in Human Breast Cancer
Contrasting correlations of mTORC1 and Rictor with clinicopathological parameters in human breast cancer: A ‘Gas and Pedal’ relationship?
Guanine nucleotide binding protein beta polypeptide: A novel transduction protein with a possible role in human breast cancer
Clinical significance of sentinel lymph node isolated tumour cells in breast cancer
The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit
Oncological Outcome & Patient Satisfaction with Skin-Sparing Mastectomy & Immediate Breast Reconstruction at The LBI: A Prospective Observational Study
Dr Nick Perry and Professor Kefah Mokbel receive continued press coverage on the topic of breast screening at 40.
Prognostic utility of glycosyltransferase expression in breast cancer.
The addition of zoledronic acid to adjuvant endocrine therapy improves disease-free survival in premenopausal patients with estrogen-responsive early breast cancer.
Breast cancer after use of estrogen plus progestin in postmenopausal women
Osteopontin expression profiles predict pathological and clinical outcome in breast cancer
Tibolone increases the risk of recurrence in breast cancer patients, while relieving vasomotor symptoms and preventing bone loss
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy
Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French Prospective Multicentric Study
Dietary Patterns and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer
Radiotherapy After Segmental Resection of Breast Cancer With Favorable Prognostic Features: 12-Year Follow-Up Results of a Randomized Trial
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells